Pennsylvania Medicaid's Spending on GLP-1s

Medicaid spending on GLP-1s exploded in Pennsylvania after the state started covering them for obesity alone. That expanded coverage ended Jan 1, a move that is expected to trim overall drug spending by $836 million in the fiscal year that starts July. Spending figures are in millions.